Asthma Clinical Trial
Official title:
The Role of Parental Perfectionistic Cognitions in an Intervention to Improve Self- Compassion and Reduce Shame: Findings in the Context of Child Chronic Health Conditions
Parents of children with long-term health conditions (LTCs) can experience shame related to parenting. Whilst self-compassion interventions (SCIs) can reduce parental shame, this has not been studied with parents of children with LTCs. Perfectionistic cognitions may also moderate the effects of SCIs. This study will test an online SCI with parents of children with type 1 diabetes, epilepsy or asthma. Parents will complete online questionnaires pre- and post a SCI/control intervention. Hypotheses will be tested using analysis of covariance and moderation analysis. Findings will enhance knowledge of vulnerability factors to distress for parents of children with LTCs, and inform interventions.
This study is part of a joint project being conducted in the University of Sheffield by
another Trainee Clinical Psychologist. The studies use the same baseline, but only this study
includes a clinical trial.
Parents of children with long-term health conditions (LTCs) can experience shame related to
parenting. Whilst self-compassion interventions (SCIs) have been shown to reduce parental
shame, this has not been studied with parents of children with LTCs. Evidence also suggests
that perfectionistic cognitions may moderate the effects of SCIs. This study will test an
online SCI with parents of children with type 1 diabetes, epilepsy or asthma.
This design of the study is experimental and prospective. The methodology is made up of two
parts:
1. Baseline data collection period:
Baseline measures of perfectionistic cognitions, state and trait self-compassion, state
shame and parental stress relating to their child's LTC will be taken, alongside
demographic information regarding the participant's age, gender, their child's type of
LTC and duration of illness (which research indicates affects levels of self-compassion
or perfectionistic cognitions).
At baseline, all participants will also be asked to give their email contact details.
Qualtrics will be set up to randomise participants' emails into one of two groups at
baseline so that participants can be allocated to one of the follow-up studies.
2. Follow-up experimental study:
Eligible participants will be randomised (as described above) into this experimental
follow-up study or that of the other Trainee Clinical Psychologist. On entry to this study
they will be further randomised via Qualtrics into an experimental (self-compassion
intervention) or control group.
Both groups will be asked to recall and write (in an online text-box) about a parenting event
during which they felt shame. Those in the experimental group will receive the online
self-compassion intervention as detailed in Sirois, Bögels and Emerson (in revision). This
involves parents in the experimental condition being given a validated set of instructions
asking them to reflect on the event and write self-compassionate responses. Participants in
the control condition will be asked to re-read the account of the event and make notes about
factual information (e.g. time of day, who was there, etc.).
Measures of state and trait self-compassion, shame and parental stress related to their
child's LTC will be repeated immediately after the intervention. The parent will then
complete a mood neutralisation task (requiring them to write about a time that they felt
proud of their parenting). Parents randomised to the control condition will receive the
self-compassion intervention retrospectively, if results indicate it was effective.
Hypotheses:
1. Parents of children with a chronic health condition will report reduced state shame
associated with parenting after the self-compassion intervention, compared with those in
the control condition.
2. Parents of children with a chronic health condition will report an increase in state
self-compassion after the self-compassion intervention, compared with those in the
control condition.
3. High levels of shame will relate to lower self-esteem and higher perfectionistic
cognitions, with a relationship present over time.
4. The intervention will be less effective for those high in perfectionistic cognitions
(i.e. will be moderated by parents' levels of PCs).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|